Schizophrenia
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
NRG3 is primarily expressed in the central nervous system and is one of three paralogs of NRG1, a gene strongly implicated in SZ.
|
19118813 |
2009 |
Schizophrenia
|
0.600 |
Biomarker
|
disease |
BEFREE |
Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition.
|
20548296 |
2011 |
Delusions
|
0.030 |
Biomarker
|
disease |
BEFREE |
Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition.
|
20548296 |
2011 |
Attention Deficit Disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Neuregulin 3 is associated with attention deficits in schizophrenia and bipolar disorder.
|
22831755 |
2013 |
Attention deficit hyperactivity disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Neuregulin 3 is associated with attention deficits in schizophrenia and bipolar disorder.
|
22831755 |
2013 |
nervous system disorder
|
0.010 |
Biomarker
|
group |
BEFREE |
Neuregulin 3 (NRG3), a brain-enriched neurotrophin, undergoes alternative splicing and is implicated in several neurological disorders with developmental origins.
|
27771971 |
2017 |
Bipolar Disorder
|
0.320 |
Biomarker
|
disease |
BEFREE |
NRG3 isoform classes I-IV were quantified using quantitative real-time polymerase chain reaction in human postmortem dorsolateral prefrontal cortex from 286 nonpsychiatric control individuals, from gestational week 14 to 85 years old, and individuals diagnosed with either bipolar disorder (N=34) or major depressive disorder (N=69).
|
27771971 |
2017 |
Unipolar Depression
|
0.010 |
Biomarker
|
disease |
BEFREE |
NRG3 class I was increased in bipolar and major depressive disorder, consistent with observations in schizophrenia.
|
27771971 |
2017 |
Major Depressive Disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
NRG3 class I was increased in bipolar and major depressive disorder, consistent with observations in schizophrenia.
|
27771971 |
2017 |
Schizophrenia
|
0.600 |
Biomarker
|
disease |
BEFREE |
Neuregulin-3 (Nrg3) is a member of the Nrg family of growth factors identified as risk factors for schizophrenia.
|
30328115 |
2019 |
Chronic schizophrenia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
NRG3 rs10748842 may not confer susceptibility to schizophrenia, but may be more closely associated with cognitive deficit, especially attention performance in chronic schizophrenia.
|
31753594 |
2020 |
Malignant neoplasm of breast
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
NRG-3 was expressed in cell lines derived from breast cancer.
|
9772300 |
1998 |
Breast Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
NRG-3 was expressed in cell lines derived from breast cancer.
|
9772300 |
1998 |
Tuberculosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A number of models were successfully validated, indicating that interplay between the NRG1 - NRG3, GRIK1 - GRIK3 and IL23R - ATG4C gene pairs may modify susceptibility to TB.
|
25919455 |
2014 |
Nicotine Dependence
|
0.020 |
Biomarker
|
disease |
BEFREE |
Although the function of the SNP in NRG3 in humans is not known, these data suggest that Nrg3/ErbB4 signaling may be an important factor in nicotine dependence.
|
23999525 |
2014 |
Cognitive changes
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Altogether, our data indicate that nicotine-induced synaptic plasticity in the OFC and cognitive changes depend on NRG3-ErbB4 signaling.
|
29114105 |
2018 |
Schizophrenia
|
0.600 |
Biomarker
|
disease |
BEFREE |
By elucidating a lack of association in a Korean population, findings from this study may contribute to the understanding of the genetic etiology focusing on the role of NRG3 in schizophrenia pathogenesis.
|
21762460 |
2011 |
Autosomal dominant compelling helio ophthalmic outburst syndrome
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Detection and interpretation of shared genetic influences on 42 human traits.
|
27182965 |
2016 |
Mammary Neoplasms
|
0.010 |
AlteredExpression
|
group |
LHGDN |
ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.
|
17962208 |
2008 |
Epstein-Barr Virus Infections
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.
|
28654678 |
2017 |
Leukemia, Myelocytic, Acute
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.
|
27903959 |
2017 |
Malignant neoplasm of breast
|
0.020 |
Biomarker
|
disease |
BEFREE |
Here evidence for a key function for NRG3 in promoting early mammary morphogenesis and the implication for the role of NRG3 in breast cancer and establishment of the mammary lineage are discussed.
|
18418701 |
2008 |
Breast Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Here evidence for a key function for NRG3 in promoting early mammary morphogenesis and the implication for the role of NRG3 in breast cancer and establishment of the mammary lineage are discussed.
|
18418701 |
2008 |
Schizophrenia
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
However, no study has investigated the effects of NRG3 polymorphism on cognitive deficits in a large sample of the patients with schizophrenia.
|
31753594 |
2020 |
Schizophrenia
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Isoform-specific increases in NRG3 are observed in schizophrenia and associated with rs10748842, a NRG3 risk polymorphism, suggesting NRG3 transcriptional dysregulation as a molecular mechanism of risk.
|
27771971 |
2017 |